Summit Therapeutics Inc (SMMT)
8.685
-2.24
(-20.47%)
USD |
NASDAQ |
May 31, 16:00
8.70
+0.02
(+0.17%)
After-Hours: 20:00
Summit Therapeutics Cash from Financing (Quarterly): 0.485M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.485M |
| December 31, 2023 | 6.252M |
| September 30, 2023 | 0.229M |
| June 30, 2023 | -0.08M |
| March 31, 2023 | 80.11M |
| December 31, 2022 | 520.06M |
| September 30, 2022 | 75.00M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 25.19M |
| December 31, 2021 | 1.261M |
| September 30, 2021 | 0.676M |
| June 30, 2021 | 20.08M |
| March 31, 2021 | 55.90M |
| December 31, 2020 | 50.55M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.003M |
| October 31, 2019 | -0.128M |
| July 31, 2019 | -0.1027M |
| April 30, 2019 | -0.1138M |
| Date | Value |
|---|---|
| January 31, 2019 | 26.71M |
| October 31, 2018 | -0.7012M |
| July 31, 2018 | -0.9956M |
| April 30, 2018 | 19.49M |
| January 31, 2018 | 1.101M |
| October 31, 2017 | 18.33M |
| July 31, 2017 | 0.0279M |
| April 30, 2017 | 0.0168M |
| January 31, 2017 | 0.0302M |
| October 31, 2016 | 0.3103M |
| July 31, 2016 | 0.0194M |
| April 30, 2016 | 0.1564M |
| January 31, 2016 | -2.628M |
| October 31, 2015 | -0.3831M |
| July 31, 2015 | 0.5674M |
| April 30, 2015 | 33.97M |
| January 31, 2015 | -2.384M |
| October 31, 2014 | -2.139M |
| July 31, 2014 | 0.1377M |
| April 30, 2014 | 34.86M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.128M
Minimum
Oct 2019
520.06M
Maximum
Dec 2022
43.97M
Average
0.676M
Median
Sep 2021
Cash from Financing (Quarterly) Benchmarks
| Merck & Co Inc | -2.814B |
| Novo Integrated Sciences Inc | 0.0032M |
| Insmed Inc | 3.022M |
| Retractable Technologies Inc | -0.1313M |
| BioCardia Inc | 1.376M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -30.13M |
| Cash from Investing (Quarterly) | 19.87M |
| Free Cash Flow | -93.84M |
| Free Cash Flow Per Share (Quarterly) | -0.0429 |
| Free Cash Flow Yield | -1.54% |